BioCentury
ARTICLE | Clinical News

Zomaril iloperidone: Safety study; Phase III

July 29, 2002 7:00 AM UTC

In a 6-week cardiac safety study comparing QTc intervals in 150 schizophrenic patients receiving either iloperidone, Geodon ziprasidone from Pfizer Inc. (PFE, New York, N.Y.) or an undisclosed marke...